7/24/2019 Singkatan Dementia

1/2

FTD Demensia Frontotemporal

AD

AChEIs Kolinesterase Inhibitor

SSRI Selective Serotonin Reuptake Inhibitor

FTLD Demensia Lobus Frontotemporal

CGI-I Clinical Global Impression o Improvement

CGI-S Clinical Global Impression o Severit!

RCT

ADAS-co" Al#heimer $isease Assessment Scale-Co"nition

%%SE %ini mental state e&amination

'(I 'E)R* (SIKIATRI I'+E'T*RI

CDR Clinical Dementia Ratin"

*R

Cl

%CI %il$ Co"nitive Impairment

,(SD ,ehavioral An$ (s!cholo"ical S!mptoms o Dementia

'ICE 'ational Institute or eatlh an$ Clinical an$ ealth E&cellence

DART-AD

SI, Severe Impairment ,atter!

*DD *ran" $en"an Demensia

,EA+E AD

''T

''

+aD $emensia vaskuler

DL, Demensia Le.! ,o$!

(DD Demensia (en!akit (arkinson

7/24/2019 Singkatan Dementia

2/2

,(RS Brief Psychiatric Rating Scale

*,RA *mnibus ,u$"et Reconciliation Act

CAL% AD Cholinesterase Inhibitor an$ At!pical 'euroleptic in the

%ana"ement o

A"itation in AD

SSRIs Selective Serotonin Reuptake Inhibitor

TCAs Tric!clic Anti$epressants

'%DA N-methyl-D-aspartate

CI,IC

SI, Severe Impairment ,atter!

ADL activities o $ail! livin"

,(SD ,ehaviour an$ (s!cholo"ical S!mptoms o Dementia

%S,T %ultisensor! ,ehavioural Therap!

EG, /01 Ekstrak Ginko ,iloba

%ID %ulti Inarct $ementia

CGC Clinical Global Impression

SKT S!n$rom-Kur#test

'A, 'urnber"er Alters-,eobachtun"skala